Brazil Multiomics Market Size & Outlook, 2025-2033

The multiomics market in Brazil is expected to reach a projected revenue of US$ 204.6 million by 2033. A compound annual growth rate of 12.4% is expected of Brazil multiomics market from 2025 to 2033.
Revenue, 2024 (US$M)
$70.7
Forecast, 2033 (US$M)
$204.6
CAGR, 2025 - 2033
12.4%
Report Coverage
Brazil

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Brazil multiomics market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Brazil multiomics market highlights

  • The Brazil multiomics market generated a revenue of USD 70.7 million in 2024 and is expected to reach USD 204.6 million by 2033.
  • The Brazil market is expected to grow at a CAGR of 12.4% from 2025 to 2033.
  • In terms of segment, product was the largest revenue generating product & service in 2024.
  • Services is the most lucrative product & service segment registering the fastest growth during the forecast period.


Multiomics market data book summary

Market revenue in 2024USD 70.7 million
Market revenue in 2033USD 204.6 million
Growth rate12.4% (CAGR from 2025 to 2033)
Largest segmentProduct
Fastest growing segmentServices
Historical data2021 - 2023
Base year2024
Forecast period2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationServices, Product
Key market players worldwideThermo Fisher Scientific Inc, Illumina Inc, Danaher Corp, Shimadzu Corp, Bruker Corp, Qiagen NV, Agilent Technologies Inc, BD, Revvity Inc, BGI Group


Other key industry trends

  • In terms of revenue, Brazil accounted for 2.6% of the global multiomics market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Latin America, Brazil multiomics market is projected to lead the regional market in terms of revenue in 2033.
  • Brazil is the fastest growing regional market in Latin America and is projected to reach USD 204.6 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Multiomics Market Companies

Name Profile # Employees HQ Website
BGI Group View profile 5001-10000 Shenzhen, Guangdong, China, Asia https://www.genomics.cn/
BD View profile 10001+ Franklin Lakes, New Jersey, United States, North America https://www.bd.com
Bruker Corp View profile 9707 40 Manning Road, Billerica, MA, United States, 01821 https://www.bruker.com
Revvity Inc View profile 11500 940 Winter Street, Waltham, MA, United States, 02451 https://www.revvity.com
Qiagen NV View profile 5900 Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL https://www.qiagen.com
Agilent Technologies Inc View profile 17700 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 https://www.agilent.com
Illumina Inc View profile 9300 5200 Illumina Way, San Diego, CA, United States, 92122 https://www.illumina.com
Danaher Corp View profile 63000 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 https://www.danaher.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
Shimadzu Corp View profile 15284 1, Nishinokyo-Kuwabara-cho, Nakagyo-ku, Kyoto, Japan, 604-8511 http://www.shimadzu.com

Brazil multiomics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to multiomics market will help companies and investors design strategic landscapes.


Product was the largest segment with a revenue share of 71.57% in 2024. Horizon Databook has segmented the Brazil multiomics market based on services, product covering the revenue growth of each sub-segment from 2021 to 2033.


Brazil has a notable reputation for the frequent occurrence of emerging infectious diseases, such as Zika, dengue, and chikungunya. For instance, Brazil has reported over 100,000 cases of the Zika virus since the conclusion of the period of Public Health Emergency of International Concern in 2016.

Moreover, in June 2023, the Brazilian Ministry of Health (MoH) notified the WHO about a fatal human case of a sporadic variant virus infection. A test conducted by the Brazil National Influenza Center identified that the virus is genetically related to swine influenza viruses detected previously in swine in Brazil. 

Thus, due to the growing incidence of infectious diseases, Brazil has witnessed significant expansion in multiomics research. On the other hand, with rise in the number of infectious disease cases and the pivotal role of multiomics in offering solutions, numerous companies are devising strategies to enhance their genomics-based endeavors in the region.

Reasons to subscribe to Brazil multiomics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Brazil multiomics market databook

  • Our clientele includes a mix of multiomics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Brazil multiomics market , including forecasts for subscribers. This country databook contains high-level insights into Brazil multiomics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Brazil multiomics market size, by product & service, 2021-2033 (US$M)

Brazil Multiomics Market Outlook Share, 2024 & 2033 (US$M)

Brazil multiomics market size, by product & service, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online